Resumen

PANNELLI, Lucía; SEBASTIAN, Silvina; GHISOLFI, Cecilia  y  STRADA, María Laura. Evaluación de los niveles de anticuerpos para COVID-19 en pacientes que concurrieron a un laboratorio de la Ciudad Autónoma de Buenos Aires. Acta bioquím. clín. latinoam. [online]. 2022, vol.56, n.3, pp.293-301. ISSN 0325-2957.

At the end of 2019 the first cases of SARS-CoV-2-associated pneumonia were reported in China. Consequently, the World Health Organization (WHO) named it COVID-19 and in January 2020, it declared the international health emergency due to the worldwide rapid spread of the infection. The first cases in Argentina were detected in early March 2020. Molecular tests like RT PCR and LAMP were immediately used. Serological tests for antibody detection were approved a few months later; however, these are still not the preferred evidiagnostic method for the disease. In our laboratory, the latter began to be used during the first wave of COVID-19. With the results obtained in that moment, an observational retrospective study in a cohort of patients who came voluntarily to test for SARS-CoV-2 IgG antibodies and whose results were positive was performed. The notification rate to the Argentine Integrated System for Health Information (SISA for its acronym in Spanish) was calculated and antibody levels were evaluated, clustering them according to the following facts: if the event had been notified to the SISA and if they had a previous RT PCR/LAMP result, the symptoms experienced by these patients and the time elapsed between RT PCR/LAMP and antibody test results. It was not possible to demonstrate differences between patients with detectable and undetectable RT PCR/LAMP, neither with the type of declared symptoms nor with respect to the days elapsed post-infection. However, it was found that there was a significant difference between notified and non-notified patients, and a high rate of non-notified patients with positive antibodies. Therefore, antibodies level might be considered as a surrogate marker of SARS-CoV-2 contact when a diagnosis through molecular methods is not available.

Palabras clave : SARS-CoV-2; Serologic test; Antibody levels; IgG; Argentina; Argentine Integrated System for Health Information.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )